Skip to main
ASND
ASND logo

Ascendis Pharma (ASND) Earnings Dates & Reports

Ascendis Pharma (ASND) Most Recent Earnings

Report DateMay 1, 2025
Period EndingQ1 2025
Est. EPS-$1.51
Actual EPS-$1.66
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Ascendis Pharma (ASND) Earnings per Share (EPS) History

Signup for full access
Browse free

Ascendis Pharma (ASND) Latest Earnings

The value each ASND share was expected to gain vs. the value each share gained.

Ascendis Pharma (ASND) reported its most recent earnings on May 1, 2025 for Q1 2025, posting earnings per share (EPS) of -$1.66. This exceeded analysts' expectations of -$1.51 by 9.93%, marking a Miss.

For comparison, Ascendis Pharma reported EPS of -$2.50 in the same quarter last year.

The company is expected to announce its next earnings report on 09/02/2025, with analysts projecting an EPS of $0.

Ascendis Pharma (ASND) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2025Sep 2, 2025
Next earnings call Sep. 2, 2025
Q1 2025May 1, 2025
-$1.51-$1.66+9.93%
DeckReportListen
Q4 2024Feb 12, 2025
-$1.20-$0.68-43.33%
Q3 2024Nov 14, 2024
-$1.52-$1.89+24.34%
Q2 2024Sep 3, 2024
-$1.56-$2.06+32.05%
View all

Ascendis Pharma (ASND) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Ascendis Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 1, 2025
Feb 12, 2025
Nov 14, 2024
Sep 3, 2024

Ascendis Pharma (ASND) Earnings FAQs

Ascendis Pharma (ASND) last reported earnings on May 1, 2025 for Q1 2025, posting an EPS of -$1.66, which Miss the estimate of -$1.51 by 9.93%.

For Q1 2025, Ascendis Pharma (ASND) reported an EPS of -$1.66, missing analysts' estimate of -$1.51 by 9.93%.

For Q1 2025, Ascendis Pharma (ASND) Miss expectations with an actual EPS of -$1.66 vs. an estimated EPS of -$1.51.

Following the last earnings report on May 1, 2025, Ascendis Pharma (ASND)'s stock price moved — from — to —.

The next Ascendis Pharma (ASND) earnings call is scheduled for Sep. 2, 2025, where executives will discuss financial results and outlook.

Ascendis Pharma (ASND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.